T Cell News and Research

Latest T Cell News and Research

SBP researchers identify new protective function for brain protein genetically linked to Alzheimer's

Researchers at Sanford Burnham Prebys Medical Discovery Institute have identified a new protective function for a brain protein genetically linked to Alzheimer's. The findings, published in the Journal of Experimental Medicine, could inform novel treatment strategies.

7 Nov 2017

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

A popular drug commonly used to treat Alzheimer's disease has shown promise in laboratory and clinical trials for treating patients with sickle cell disease (SCD).

7 Nov 2017

Mental stress and anticipation of pain may trigger painful sickle cell episodes

Mental stress and the anticipation of pain may cause blood vessels to narrow and trigger episodes of severe pain (vaso-occlusive crisis, or VOC) in sickle cell disease (SCD).

7 Nov 2017

Study shows promise and potential risk in reversing hearing loss using inner ear stem cells

Want to restore hearing by injecting stem cells into the inner ear? Well, that can be a double-edged sword.

7 Nov 2017

UMD study provides important insights into early sensory development

Some expectant parents play classical music for their unborn babies, hoping to boost their children's cognitive capacity later in life.

7 Nov 2017

Johns Hopkins scientists report first-ever creation of protein hydrogels inside living cells

Johns Hopkins cell biologists report what they believe is the first-ever creation of tiny protein-based gelatin-like clumps called hydrogels inside living cells.

7 Nov 2017

Researchers to test use of ‘viral specific’ T-cells to target toxic viruses in children

Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with Michael Keller, MD from Children's National Health System in Washington, DC, have been awarded $4.8 million by the California Institute for Regenerative Medicine to study the use of a new T-cell therapy to help fight active viral infections in children with severe immune deficiencies.

7 Nov 2017

FDA approves first targeted cancer treatment based on basket study

The US Food and Drug Administration has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD).

7 Nov 2017

Immune system plays surprising role in the aftermath of heart attacks, study finds

A study led by Kevin King, a bioengineer and physician at the University of California San Diego, has found that the immune system plays a surprising role in the aftermath of heart attacks. The research could lead to new therapeutic strategies for heart disease.

7 Nov 2017

FDA grants approval to first treatment for rare blood cancer

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.

7 Nov 2017

Fat hormone associated with NASH may be effective target for therapeutic intervention

The rising obesity epidemic has brought with it an army of maladies. One, in particular, is threatening to outpace many of the disorders that accompany obesity, in terms of occurrence and severity: nonalcoholic fatty liver disease.

7 Nov 2017

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

Italian researchers have demonstrated a better way of determining the aggressiveness of tumors in patients with advanced non-small cell lung cancer (NSCLC).

7 Nov 2017

FDA grants clearance to new blood cell count test that allows faster availability of results

The U.S. Food and Drug Administration today cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more health care settings, including physicians' offices, clinics or other types of health care facilities, by a wider range of personnel (e.g. support staff). This broadened test access will allow for faster availability of results.

6 Nov 2017

FDA approves new drug Zelboraf for Erdheim-Chester disease

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

6 Nov 2017

Sleepless nights lead to sluggish brain activity

A new study has shown that some brain cells actually slow down if a person has not got adequate sleep at night. This leads to periods of mental lapses. Researchers of University of California, Los Angeles (UCLA) and Tel Aviv University have proven this in their published study that appeared in the journal Nature Medicine online this Monday (6th of November 2017).

6 Nov 2017

Special electric dressing can combat antibiotic resistance, biofilm infection

Researchers at The Ohio State University Wexner Medical Center have shown - for the first time - that special bandages using weak electric fields to disrupt bacterial biofilm infection can prevent infections, combat antibiotic resistance and enable healing in infected burn wounds.

6 Nov 2017

Gelatin promotes faster healing of the blood brain barrier after injury

Researchers already know that gelatin-covered electrode implants cause less damage to brain tissue than electrodes with no gelatin coating. Researchers at the Neuronano Research Centre at Lund University in Sweden have now shown that microglia, the brain's cleansing cells, and the enzymes that the cells use in the cleaning process, change in the presence of gelatin.

6 Nov 2017

T Cell News and Research

Latest T Cell News and Research

SBP researchers identify new protective function for brain protein genetically linked to Alzheimer's

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

Mental stress and anticipation of pain may trigger painful sickle cell episodes

Study shows promise and potential risk in reversing hearing loss using inner ear stem cells

UMD study provides important insights into early sensory development

Johns Hopkins scientists report first-ever creation of protein hydrogels inside living cells

Researchers to test use of ‘viral specific’ T-cells to target toxic viruses in children

FDA approves first targeted cancer treatment based on basket study

Immune system plays surprising role in the aftermath of heart attacks, study finds

FDA grants approval to first treatment for rare blood cancer

Fat hormone associated with NASH may be effective target for therapeutic intervention

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

FDA grants clearance to new blood cell count test that allows faster availability of results

FDA approves new drug Zelboraf for Erdheim-Chester disease

Sleepless nights lead to sluggish brain activity

Special electric dressing can combat antibiotic resistance, biofilm infection

Gelatin promotes faster healing of the blood brain barrier after injury

Uncovering Bacterial Cell Wall Secrets To Combat Antibiotic Resistance

Researchers discover how traffic jam in intracellular sorting can cause tumor development

New study finds huge disparities in survival for patients with HPV-related cancers

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in